Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
British journal of clinical pharmacology - 74(2012), 6 vom: Dez., Seite 971-978 |
| Beteiligte Personen: |
Bouazza, Naïm [VerfasserIn] |
|---|
| RVK: |
|---|
| Umfang: |
7 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1906806799 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1906806799 | ||
| 003 | DE-627 | ||
| 005 | 20230516101322.0 | ||
| 007 | tu | ||
| 008 | 121114s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw121113_1 |
| 035 | |a (DE-627)OLC1906806799 | ||
| 035 | |a (DE-599)GBVOLC1906806799 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a XA 33650 |q AVZ |2 rvk | ||
| 100 | 1 | |a Bouazza, Naïm |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis |
| 264 | 1 | |c 2012 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Pestre, Vincent |4 oth | |
| 700 | 1 | |a Jullien, Vincent |4 oth | |
| 700 | 1 | |a Curis, Emmanuel |4 oth | |
| 700 | 1 | |a Urien, Saïk |4 oth | |
| 700 | 1 | |a Salmon, Dominique |4 oth | |
| 700 | 1 | |a Tréluyer, Jean‐Marc |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of clinical pharmacology |d Oxford : Wiley-Blackwell, 1974 |g 74(2012), 6 vom: Dez., Seite 971-978 |w (DE-627)129413496 |w (DE-600)188974-6 |w (DE-576)014792648 |x 0306-5251 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2012 |g number:6 |g month:12 |g pages:971-978 |g extent:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 33650 |
| 951 | |a AR | ||
| 952 | |d 74 |j 2012 |e 6 |c 12 |h 971-978 |g 7 | ||